X3 Holdings to Commercialize AI Healthcare Smartwatch Monitoring 27 Brain Points
On February 24, X3 Holdings secured a global partnership to commercialize an AI-powered healthcare smartwatch that monitors 27 brain-related points via a non-invasive sensing chip. The device processes real-time signals through cloud AI analytics built on 7 million user records and 25,000 physiological indicators, with revenue beginning March 2026.
1. Partnership Scope
On February 24, X3 Holdings entered a global agreement to manage the commercialization and operational deployment of an AI-powered healthcare smartwatch. The company will handle international marketing, distribution logistics and service support for the neuro-digital wearable device.
2. Smartwatch Technology
The smartwatch integrates a non-invasive brainwave sensing chip with digital frequency modulation to target 27 functional brain-related points. Continuous adaptive intervention is enabled by real-time monitoring of emotional and neurological balance without pharmaceuticals.
3. AI Analytics Platform
Data collected by the device feeds into a cloud-based AI analytics engine built on 7 million user records and 25,000 physiological indicators. This closed-loop system processes live signals to adjust frequency outputs and optimize long-term physiological stability.
4. Revenue and Outlook
X3 Holdings expects to record its first service contract revenue under the partnership starting in March 2026. The entry into AI healthcare represents a strategic diversification beyond its existing software and technology services business in China.